Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Płuciennik E[au]:

Search results

Items: 40

1.

Exosomes as carriers transporting long non‑coding RNAs: Molecular characteristics and their function in cancer (Review).

Kołat D, Hammouz R, Bednarek AK, Płuciennik E.

Mol Med Rep. 2019 Jun 5. doi: 10.3892/mmr.2019.10340. [Epub ahead of print]

PMID:
31173220
2.

A Novel Set of WNT Pathway Effectors as a Predictive Marker of Uterine Corpus Endometrial Carcinoma-Study Based on Weighted Co-expression Matrices.

Kośla K, Orzechowska M, Jędroszka D, Baryła I, Bednarek AK, Płuciennik E.

Front Oncol. 2019 May 10;9:360. doi: 10.3389/fonc.2019.00360. eCollection 2019.

3.

The biological characteristics of transcription factors AP-2α and AP-2γ and their importance in various types of cancers.

Kołat D, Kałuzińska Ż, Bednarek AK, Płuciennik E.

Biosci Rep. 2019 Mar 15;39(3). pii: BSR20181928. doi: 10.1042/BSR20181928. Print 2019 Mar 29. Review.

4.

Placental Expression of NEMO Protein in Normal Pregnancy and Preeclampsia.

Sakowicz A, Lisowska M, Biesiada L, Płuciennik E, Gach A, Rybak-Krzyszkowska M, Huras H, Sakowicz B, Romanowicz H, Piastowska-Ciesielska AW, Grzesiak M, Pietrucha T.

Dis Markers. 2019 Jan 2;2019:8418379. doi: 10.1155/2019/8418379. eCollection 2019.

5.

WWOX Tumor Suppressor Gene in Breast Cancer, a Historical Perspective and Future Directions.

Pospiech K, Płuciennik E, Bednarek AK.

Front Oncol. 2018 Aug 28;8:345. doi: 10.3389/fonc.2018.00345. eCollection 2018. Review.

6.

Silencing of angiotensin receptor 1 interferes with angiotensin II oncogenic activity in endometrial cancer.

Matysiak-Burzyńska ZE, Nowakowska M, Domińska K, Kowalska K, Płuciennik E, Piastowska-Ciesielska AW.

J Cell Biochem. 2018 Nov;119(11):9110-9121. doi: 10.1002/jcb.27174. Epub 2018 Aug 13.

PMID:
30105775
7.

Regulation of mRNA gene expression of members of the NF-κB transcription factor gene family by angiotensin II and relaxin 2 in normal and cancer prostate cell lines.

Domińska K, Kowalska K, Matysiak ZE, Płuciennik E, Ochędalski T, Piastowska-Ciesielska AW.

Mol Med Rep. 2017 Jun;15(6):4352-4359. doi: 10.3892/mmr.2017.6514. Epub 2017 Apr 26.

PMID:
28487955
8.

Angiotensin II promotes endometrial cancer cell survival.

Nowakowska M, Matysiak-Burzyńska Z, Kowalska K, Płuciennik E, Domińska K, Piastowska-Ciesielska AW.

Oncol Rep. 2016 Aug;36(2):1101-10. doi: 10.3892/or.2016.4887. Epub 2016 Jun 21.

PMID:
27349856
9.

A common effect of angiotensin II and relaxin 2 on the PNT1A normal prostate epithelial cell line.

Domińska K, Ochędalski T, Kowalska K, Matysiak-Burzyńska ZE, Płuciennik E, Piastowska-Ciesielska AW.

J Physiol Biochem. 2016 Sep;72(3):381-92. doi: 10.1007/s13105-016-0489-1. Epub 2016 Apr 27.

PMID:
27119161
10.

Interaction between angiotensin II and relaxin 2 in the progress of growth and spread of prostate cancer cells.

Domińska K, Ochędalski T, Kowalska K, Matysiak-Burzyńska ZE, Płuciennik E, Piastowska-Ciesielska AW.

Int J Oncol. 2016 Jun;48(6):2619-28. doi: 10.3892/ijo.2016.3458. Epub 2016 Mar 24.

PMID:
27035428
11.

The influence of the WWOX gene on the regulation of biological processes during endometrial carcinogenesis.

Płuciennik E, Nowakowska M, Gałdyszyńska M, Popęda M, Bednarek AK.

Int J Mol Med. 2016 Mar;37(3):807-15. doi: 10.3892/ijmm.2016.2469. Epub 2016 Jan 27.

PMID:
26820701
12.

Finding NEMO in preeclampsia.

Sakowicz A, Hejduk P, Pietrucha T, Nowakowska M, Płuciennik E, Pospiech K, Gach A, Rybak-Krzyszkowska M, Sakowicz B, Kaminski M, Krasomski G, Biesiada L.

Am J Obstet Gynecol. 2016 Apr;214(4):538.e1-538.e7. doi: 10.1016/j.ajog.2015.11.002. Epub 2015 Nov 10.

PMID:
26571191
13.

The role of WWOX tumor suppressor gene in the regulation of EMT process via regulation of CDH1-ZEB1-VIM expression in endometrial cancer.

Płuciennik E, Nowakowska M, Pospiech K, Stępień A, Wołkowicz M, Gałdyszyńska M, Popęda M, Wójcik-Krowiranda K, Bieńkiewicz A, Bednarek AK.

Int J Oncol. 2015;46(6):2639-48. doi: 10.3892/ijo.2015.2964. Epub 2015 Apr 16.

PMID:
25892250
14.

Alternating expression levels of WWOX tumor suppressor and cancer-related genes in patients with bladder cancer.

Płuciennik E, Nowakowska M, Stępien A, Wołkowicz M, Stawiński A, Różański W, Lipiński M, Bednarek AK.

Oncol Lett. 2014 Nov;8(5):2291-2297. Epub 2014 Aug 22.

15.

[Proteins in cancer multidrug resistance].

Popęda M, Płuciennik E, Bednarek AK.

Postepy Hig Med Dosw (Online). 2014 May 20;68:616-32. doi: 10.5604/17322693.1103268. Review. Polish.

16.

The correlation analysis of WWOX expression and cancer related genes in neuroblastoma- a real time RT-PCR study.

Nowakowska M, Płuciennik E, Wujcicka WI, Sitkiewicz A, Kazanowska B, Zielińska E, Bednarek AK.

Acta Biochim Pol. 2014;61(1):91-7. Epub 2014 Jan 22.

17.

The WWOX tumor suppressor gene in endometrial adenocarcinoma.

Płuciennik E, Kośla K, Wójcik-Krowiranda K, Bieńkiewicz A, Bednarek AK.

Int J Mol Med. 2013 Dec;32(6):1458-64. doi: 10.3892/ijmm.2013.1526. Epub 2013 Oct 11.

PMID:
24126431
18.

Primary extranodal marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue type in the central nervous system (MZL CNS) presented as traumatic subdural hematoma and subarachnoid bleeding - case report.

Jesionek-Kupnicka D, Smolewski P, Kupnicki P, Pluciennik E, Zawlik I, Papierz W, Kordek R.

Clin Neuropathol. 2013 Sep-Oct;32(5):384-92. doi: 10.5414/NP300579.

PMID:
23557903
19.

Correlation between VEGFR-2 receptor kinase domain-containing receptor (KDR) mRNA and angiotensin II receptor type 1 (AT1-R) mRNA in endometrial cancer.

Piastowska-Ciesielska AW, Płuciennik E, Wójcik-Krowiranda K, Bieńkiewicz A, Nowakowska M, Pospiech K, Bednarek AK, Domińska K, Ochędalski T.

Cytokine. 2013 Feb;61(2):639-44. doi: 10.1016/j.cyto.2012.11.017. Epub 2012 Dec 28.

PMID:
23273598
20.

Genetic alterations of WWOX in Wilms' tumor are involved in its carcinogenesis.

Płuciennik E, Nowakowska M, Wujcicka WI, Sitkiewicz A, Kazanowska B, Zielińska E, Bednarek AK.

Oncol Rep. 2012 Oct;28(4):1417-22. doi: 10.3892/or.2012.1940. Epub 2012 Jul 27.

PMID:
22842668
21.

A comparison of the effects of Angiotensin IV on androgen-dependent and androgen-independent prostate cancer cell lines.

Dominska K, Piastowska-Ciesielska AW, Pluciennik E, Lachowicz-Ochedalska A, Ochedalski T.

J Renin Angiotensin Aldosterone Syst. 2013 Mar;14(1):74-81. doi: 10.1177/1470320312447649. Epub 2012 Jun 7.

PMID:
22679277
22.

Analysis of the expression of angiotensin II type 1 receptor and VEGF in endometrial adenocarcinoma with different clinicopathological characteristics.

Piastowska-Ciesielska AW, Płuciennik E, Wójcik-Krowiranda K, Bieńkiewicz A, Bednarek A, Ochędalski T.

Tumour Biol. 2012 Jun;33(3):767-74. doi: 10.1007/s13277-011-0292-0. Epub 2011 Dec 15.

PMID:
22170435
23.

WWOX expression in colorectal cancer--a real-time quantitative RT-PCR study.

Żelazowski MJ, Płuciennik E, Pasz-Walczak G, Potemski P, Kordek R, Bednarek AK.

Tumour Biol. 2011 Jun;32(3):551-60. doi: 10.1007/s13277-010-0150-5. Epub 2011 Feb 25.

24.

Molecular analysis of WWOX expression correlation with proliferation and apoptosis in glioblastoma multiforme.

Kosla K, Pluciennik E, Kurzyk A, Jesionek-Kupnicka D, Kordek R, Potemski P, Bednarek AK.

J Neurooncol. 2011 Jan;101(2):207-13. doi: 10.1007/s11060-010-0254-1. Epub 2010 Jun 10.

25.

Basal keratin expression in breast cancer by quantification of mRNA and by immunohistochemistry.

Kordek R, Potemski P, Kusinska R, Pluciennik E, Bednarek A.

J Exp Clin Cancer Res. 2010 Apr 28;29:39. doi: 10.1186/1756-9966-29-39.

26.

Breast cancer relapse prediction based on multi-gene RT-PCR algorithm.

Pluciennik E, Krol M, Nowakowska M, Kusinska R, Potemski P, Kordek R, Bednarek AK.

Med Sci Monit. 2010 Mar;16(3):CR132-136.

PMID:
20190683
27.

Does vimentin help to delineate the so-called 'basal type breast cancer'?

Kusinska RU, Kordek R, Pluciennik E, Bednarek AK, Piekarski JH, Potemski P.

J Exp Clin Cancer Res. 2009 Aug 20;28:118. doi: 10.1186/1756-9966-28-118.

28.

WWOX, the tumour suppressor gene affected in multiple cancers.

Lewandowska U, Zelazowski M, Seta K, Byczewska M, Pluciennik E, Bednarek AK.

J Physiol Pharmacol. 2009 May;60 Suppl 1:47-56. Review.

29.

Prognostic relevance of cyclin E expression in operable breast cancer.

Potemski P, Kusińska R, Pasz-Walczak G, Piekarski JH, Watała C, Płuciennik E, Bednarek AK, Kordek R.

Med Sci Monit. 2009 Feb;15(2):MT34-40.

PMID:
19179977
30.

Relationship of P-cadherin expression to basal phenotype of breast carcinoma.

Potemski P, Kusińska R, Kubiak R, Piekarski JH, Płuciennik E, Bednarek AK, Kordek R.

Pol J Pathol. 2007;58(3):183-8.

PMID:
18074863
31.

Evaluation of oestrogen receptor expression in breast cancer by quantification of mRNA.

Potemski P, Pluciennik E, Bednarek AK, Kusinska R, Kubiak R, Kordek R.

Histopathology. 2007 Dec;51(6):829-36.

PMID:
18042072
32.

Primary osseous rhabdomyosarcoma with focal matrix formation mimicking osteosarcoma.

Kordek R, Sowa P, Panasiuk M, Kmieciak M, Chudobinski C, Pluciennik E, Bednarek AK, Potemski P, Jesionek-Kupnicka D.

Pathol Res Pract. 2007;203(12):873-7. Epub 2007 Oct 1.

PMID:
17905523
33.

A comparative assessment of HER2 status in operable breast cancer by real-time RT-PCR and by immunohistochemistry.

Potemski P, Płuciennik E, Bednarek AK, Kusińska R, Pasz-Walczak G, Jesionek-Kupnicka D, Watala C, Kordek R.

Med Sci Monit. 2006 Dec;12(12):MT57-61. Epub 2006 Nov 23.

PMID:
17136015
34.

Cyclin E expression in breast cancer correlates with negative steroid receptor status, HER2 expression, tumor grade and proliferation.

Potemski P, Kusinska R, Watala C, Pluciennik E, Bednarek AK, Kordek R.

J Exp Clin Cancer Res. 2006 Mar;25(1):59-64.

PMID:
16761619
35.

Ki-67 expression in operable breast cancer: a comparative study of immunostaining and a real-time RT-PCR assay.

Potemski P, Pluciennik E, Bednarek AK, Kusinska R, Kubiak R, Jesionek-Kupnicka D, Watala C, Kordek R.

Pathol Res Pract. 2006;202(7):491-5. Epub 2006 May 6.

PMID:
16678980
36.

Cyclin E expression in operable breast cancer quantified using real-time RT-PCR: a comparative study with immunostaining.

Potemski P, Pluciennik E, Bednarek AK, Kusinska R, Jesionek-Kupnicka D, Pasz-Walczak G, Watala C, Kordek R.

Jpn J Clin Oncol. 2006 Mar;36(3):142-9. Epub 2006 Mar 6.

PMID:
16520356
37.

Prognostic relevance of basal cytokeratin expression in operable breast cancer.

Potemski P, Kusinska R, Watala C, Pluciennik E, Bednarek AK, Kordek R.

Oncology. 2005;69(6):478-85. Epub 2006 Jan 12.

PMID:
16410686
38.

WWOX--the FRA16D cancer gene: expression correlation with breast cancer progression and prognosis.

Płuciennik E, Kusińska R, Potemski P, Kubiak R, Kordek R, Bednarek AK.

Eur J Surg Oncol. 2006 Mar;32(2):153-7. Epub 2005 Dec 15.

PMID:
16360296
39.

GADD45A and EPB41 as tumor suppressor genes in meningioma pathogenesis.

Piaskowski S, Rieske P, Szybka M, Wozniak K, Bednarek A, Płuciennik E, Jaskolski D, Sikorska B, Liberski PP.

Cancer Genet Cytogenet. 2005 Oct 1;162(1):63-7.

PMID:
16157202
40.

[The influence of thrombopoietin (TpO) on human erythropoiesis. In vitro studies--clinical implications].

Machaliński B, Marlicz W, Płuciennik E, Ratajczak J, Ratajczak MZ.

Pol Arch Med Wewn. 1997 Apr;97(4):307-15. Polish.

PMID:
9411407

Supplemental Content

Loading ...
Support Center